Noven Pharmaceuticals Inc. has recalled several lots of Daytrana (methylphenidate transdermal system) CII patches, a prescription medication used to treat ADHD. The recall was initiated because the patches may have a defective delivery system that failed adhesive shear testing. This defect affects the 10mg, 15mg, 20mg, and 30mg dosage strengths sold in 30-count cartons.
The defective adhesive system means the patches may not adhere properly to the skin or may be difficult to remove from the liner, potentially leading to improper medication delivery or skin irritation.
You have 2 options:
Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc.
Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc.
Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc.
Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.